APTASIGN
LIVE

Serial Number

79252467

Owner

BIOIS Co., Ltd

Attorney

Kisuk Lee

Filing Date

Dec 11, 2018

Add to watchlist:

No watchlists yet
View on USPTO

APTASIGN Trademark

Serial Number: 79252467 • Registration: 6160568

APTASIGN is a trademark filed by BIOIS Co., Ltd on December 11, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

BIOIS Co., Ltd (3 trademarks)

No. 703, 30 Digital-ro 32-gil,

Entity Type: 03

Trademark Details

Filing Date

December 11, 2018

Registration Date

September 29, 2020

Published for Opposition

July 14, 2020

Goods & Services

Medical diagnostic reagents for immunization from disease; diagnostic test reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; preparations for detecting genetic predispositions for medical purposes; diagnostic preparations for medical purposes for detecting genetic predispositions; reagents for use in medical genetic testing; in vitro diagnostic preparations for medical purposes; clinical diagnostic reagents for medical or veterinary purposes; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for diagnosis for medical or veterinary purposes; reagents for use in veterinary genetic testing; antibodies for medical purposes; aptamers for medical purposes; diagnostic antibodies for medical purposes; diagnostic aptamers for medical purposes

Medical and healthcare services relating to DNA and genetics analysis and diagnosis and genetic testing; medical analysis services relating to the treatment of persons; physical examination services; medical services relating to the removal, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bone marrow; medical analysis for the diagnosis and treatment of persons; RNA or DNA analysis for cancer diagnosis and prognosis; medical analysis services for cancer diagnosis and prognosis; genetic testing for medical purposes; provision of genetic testing for medical treatment purposes; provision of genetic information for medical treatment purposes; medical examination services; rental of medical machines and apparatus; rental of medical apparatus; performing medical diagnostic services involving medical testing and analysis for diagnostic and treatment purposes; medical testing services relating to the diagnosis and treatment of disease; Medical analysis services for the analysis of blood samples for diagnostic and treatment purposes provided by a medical laboratory; Medical analysis services for the analysis of samples taken from patients for diagnostic and treatment purposes provided by a medical laboratory; Medical analysis services for the analysis of blood samples taken from patients for diagnostic and treatment purposes provided by a medical laboratory

Medical apparatus and instruments, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical apparatus and instruments other than for dental purposes, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; apparatus for use in medical analysis, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical genetic testing devices, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical instruments in the nature of genetic fragment analyzers; medical instruments in the nature of genetic material analyzers; medical absorption analysis apparatus, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; DNA extraction and purification apparatus for medical purposes; medical apparatus and instruments in the fields of clinical diagnostics, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; body composition analyzers for medical purposes; body fluid analysis apparatus, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; in vitro diagnostic devices, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical apparatus and instruments for DNA analysis, other than for dental purposes; medical apparatus and instruments for RNA analysis, other than for dental purposes; medical apparatus and instruments for protein analysis, other than for dental purposes; gene and genetic testing apparatus, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; cancer diagnosis apparatus, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; diagnostic apparatus for medical purposes, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical body composition monitor; medical apparatus and instruments in the fields of clinical diagnostics, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; immunoassay apparatus for diagnostics, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; miniaturized sensors for medical use in gene analysis and diagnosis; veterinary apparatus and instruments for DNA analysis; veterinary apparatus and instruments for RNA analysis; veterinary apparatus and instruments for protein analysis

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 29, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 6, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 15, 2021 FICS
FINAL DISPOSITION PROCESSED
Jan 15, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 29, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 29, 2020 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 7, 2020 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 22, 2020 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 22, 2020 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 14, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 14, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 24, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 10, 2020 CNSA
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Oct 28, 2019 LOPR
LETTER OF PROTEST EVIDENCE FORWARDED
Oct 17, 2019 LOPT
EXAMINER'S AMENDMENT ENTERED
Sep 25, 2019 XAEC
ASSIGNED TO LIE
Sep 24, 2019 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 24, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 24, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 24, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 14, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 13, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 13, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 26, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 26, 2019 REAP
REFUSAL PROCESSED BY IB
Apr 12, 2019 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 28, 2019 RFCS
REFUSAL PROCESSED BY MPU
Mar 28, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 20, 2019 RFCR
NON-FINAL ACTION WRITTEN
Mar 19, 2019 CNRT
ASSIGNED TO EXAMINER
Mar 8, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 2, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 26, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 21, 2019 REPR